Neoadjuvant Chemoradiation for Rectal Cancer: Analysis of Clinical Outcomes From a 13-Year Institutional Experience - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant Chemoradiation for Rectal Cancer: Analysis of Clinical Outcomes From a 13-Year Institutional Experience

DOI Full Paper Access

157

Citations

35

References

2001

Year

Mark W. Onaitis, R. Barrett Noone, Matthew G. Hartwig, Herbert I. Hurwitz, Michael A. Morse, Paul S. Jowell, Kevin McGrath, Catherine Lee, Mitchell S. Anscher, Bryan M. Clary,

Annals of Surgery

Abstract

Neoadjuvant chemoradiation is safe, effective, and well tolerated. Postoperative lymph node status is the only independent predictor of recurrence and survival.

References

	Year	Citations

Page 1